This is a preprint.
Integrative determination of the atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington's disease
- PMID: 37502911
- PMCID: PMC10370190
- DOI: 10.1101/2023.07.21.549993
Integrative determination of the atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington's disease
Update in
-
Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease.Nat Commun. 2024 Dec 30;15(1):10793. doi: 10.1038/s41467-024-55062-8. Nat Commun. 2024. PMID: 39737997 Free PMC article.
Abstract
Neurodegeneration in Huntington's disease (HD) is accompanied by the aggregation of fragments of the mutant huntingtin protein, a biomarker of disease progression. A particular pathogenic role has been attributed to the aggregation-prone huntingtin exon 1 (HTTex1), generated by aberrant splicing or proteolysis, and containing the expanded polyglutamine (polyQ) segment. Unlike amyloid fibrils from Parkinson's and Alzheimer's diseases, the atomic-level structure of HTTex1 fibrils has remained unknown, limiting diagnostic and treatment efforts. We present and analyze the structure of fibrils formed by polyQ peptides and polyQ-expanded HTTex1 in vitro. Atomic-resolution perspectives are enabled by an integrative analysis and unrestrained all-atom molecular dynamics (MD) simulations incorporating experimental data from electron microscopy (EM), solid-state NMR, and other techniques. Alongside the use of prior data, we report new magic angle spinning NMR studies of glutamine residues of the polyQ fibril core and surface, distinguished via hydrogen-deuterium exchange (HDX). Our study provides a new understanding of the structure of the core as well as surface of aggregated HTTex1, including the fuzzy coat and polyQ-water interface. The obtained data are discussed in context of their implications for understanding the detection of such aggregates (diagnostics) as well as known biological properties of the fibrils.
Conflict of interest statement
Competing Interests The authors declare no competing interests.
Figures








Similar articles
-
Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease.Nat Commun. 2024 Dec 30;15(1):10793. doi: 10.1038/s41467-024-55062-8. Nat Commun. 2024. PMID: 39737997 Free PMC article.
-
Selective observation of semi-rigid non-core residues in dynamically complex mutant huntingtin protein fibrils.J Struct Biol X. 2022 Nov 11;6:100077. doi: 10.1016/j.yjsbx.2022.100077. eCollection 2022. J Struct Biol X. 2022. PMID: 36419510 Free PMC article.
-
Concentration-dependent structural transition of huntingtin protein in Huntington's disease.Biophys Chem. 2025 Oct;325:107473. doi: 10.1016/j.bpc.2025.107473. Epub 2025 Jun 4. Biophys Chem. 2025. PMID: 40482382
-
Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.Biochem Soc Trans. 2024 Apr 24;52(2):719-731. doi: 10.1042/BST20230731. Biochem Soc Trans. 2024. PMID: 38563485 Free PMC article. Review.
-
Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.Essays Biochem. 2014;56:167-80. doi: 10.1042/bse0560167. Essays Biochem. 2014. PMID: 25131594 Review.
References
-
- Ross C. A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington’s disease and related disorders. Neuron 35, 819–822 (2002). - PubMed
-
- Bates G. P. et al. Huntington disease. Nature Reviews Disease Primers 1, 1–21 (2015). - PubMed
-
- DiFiglia M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997). - PubMed
-
- Bauerlein F. J.¨ et al. In situ architecture and cellular interactions of polyq inclusions. Cell 171, 179–187 (2017). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources